CATALAYER NEWS
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
Source: CNBC Top · 2026-08-27
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
MORE FROM CNBC TOP
Friday's big stock stories: What’s likely to move the market in the next trading session
2026-08-27
Jim Cramer says Nvidia and Salesforce earnings upended two bear narratives
2026-08-27
Stocks making the biggest moves after hours: Gap, Workday, Autodesk and more
2026-08-27
Gap announces new Old Navy CEO following sluggish quarterly sales
2026-08-27
UAE ‘spy sheikh’ backs 49% stake in Trump family’s crypto bank venture, WSJ reports
2026-08-27
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets